Ann: Immuron CEO to present at Emerging Growth Conference, page-7

It's notable that Steve doesn't say much about ETEC which appears an exciting prospect as it's two trails in one


While the Travelan ph4 is Partner sponsored USU are using our marketed OTC product
but CampETEC is IMCs only 100% military funded and military sponsored program so I'm guessing it's not IMCs program to comment on, and Steve can only say what NMRC/Johns Hopkins Bloomberg School of Public Health allow him to say.


Also notable is that despite the top line readout being Sept'24 (note a change from Aug'24) the trail completion date is now Sept 2025 which may suggest that NMRC/Johns Hopkins have further trail plans

This product if successful may have more military and humanitarian (considering the number of children <5 afflicted the numbers are staggering) use than consumer and that might be why the plans maybe difficult for Steve to comment on.